Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Psyched Wellness makes pre-clinical progress with its Amanita Muscaria-derived wellness product

Psyched Wellness makes pre-clinical progress with its Amanita Muscaria-derived wellness product

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) CEO Jeff Stevens tells Proactive the Canadian-based health supplements company specializing in mushroom-derived products is making progress with its Amanita Muscaria mushroom extract.

Stevens says the group has begun pre-clinical studios with Amanita Muscaria, and will look to apply to the FDA as a dietary ingredient and Health Canada for a natural health product when it is completed.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK